Obesity, obesity-related metabolic conditions, and risk of thyroid cancer in women: results from a prospective cohort study (Sister Study)

被引:14
作者
Pasqual, Elisa [1 ]
O'Brien, Katie [2 ]
Rinaldi, Sabina [3 ]
Sandler, Dale P. [2 ]
Kitahara, Cari M. [1 ,4 ]
机构
[1] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA
[2] NIEHS, Epidemiol Branch, Durham, NC USA
[3] Int Agcy Res Canc, 25 Ave Tony Garnier, CS 90627, F-69366 Lyon 07, France
[4] NCI, Div Canc Epidemiol & Genet, 9609 Med Ctr Dr, Rm 7E-456, Bethesda, MD 20892 USA
来源
LANCET REGIONAL HEALTH-AMERICAS | 2023年 / 23卷
基金
美国国家卫生研究院;
关键词
Thyroid cancer; Obesity; Obesity associated diseases; Diabetes; Risk factors; Epidemiology; POOLED ANALYSIS; ASSOCIATION; METFORMIN; BREAST;
D O I
10.1016/j.lana.2023.100537
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Thyroid cancer incidence has increased worldwide. Obesity trends may play a role, but the underlying biological pathways are not well-characterized. Therefore, we examined associations of excess adiposity and obesityrelated metabolic conditions with thyroid cancer incidence. Methods From the Sister Study, a cohort of sisters of women with breast cancer, we included 47,739 women who were cancer-free at baseline (2003-2009). Height, weight, waist and hip circumference, and blood pressure were measured at baseline and medical history was self-reported. Cox proportional hazards regression models were adjusted for age (time scale), race/ethnicity, smoking, baseline history of benign thyroid disease, and frequency of routine healthcare visits. Findings During follow-up (median = 12.5; max = 15.9 years), 259 women reported incident thyroid cancer. Body mass index (BMI) (hazard ratio [HR] (per-5 kg/m)2 = 1.25, 95% CI = 1.14-1.37), waist circumference (HRper- 5 cm increase = 1.11, 95% CI = 1.06-1.15), and waist-to-hip ratio (HR (>= 0.85-versus-<0.85) = 1.49, 95% CI = 1.14-1.94) were positively associated with thyroid cancer incidence, as were metabolic syndrome (HR = 1.67, 95% CI = 1.24-2.25), dyslipidemia (HR = 1.46, 95% CI = 1.13-1.90), borderline diabetes (HR = 2.06, 95% CI = 1.15-3.69), hypertension (HR = 1.49, 95% CI = 1.12-1.96), and polycystic ovary syndrome (PCOS, HR = 2.10, 95% CI = 1.20-3.67). These associations were attenuated with additional BMI adjustment, although dyslipidemia (HR = 1.35, 95% CI = 1.04-1.75) and PCOS (HR = 1.86, 95% CI = 1.06-3.28) remained associated with thyroid cancer incidence. Hypothyroidism was not associated with thyroid cancer. Interpretation In this cohort of sisters of women diagnosed with breast cancer, excess adiposity and several obesityrelated metabolic conditions were associated with thyroid cancer incidence. These findings provide insights into potential biological mechanisms linking obesity and thyroid cancer.
引用
收藏
页数:11
相关论文
共 33 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]   Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can) [J].
Almquist, Martin ;
Johansen, Dorthe ;
Bjorge, Tone ;
Ulmer, Hanno ;
Lindkvist, Bjorn ;
Stocks, Tanja ;
Hallmans, Goran ;
Engeland, Anders ;
Rapp, Kilian ;
Jonsson, Hakan ;
Selmer, Randi ;
Diem, Guenter ;
Haggstrom, Christel ;
Tretli, Steinar ;
Stattin, Par ;
Manjer, Jonas .
CANCER CAUSES & CONTROL, 2011, 22 (05) :743-751
[4]   Benign Breast and Gynecologic Conditions, Reproductive and Hormonal Factors, and Risk of Thyroid Cancer [J].
Braganza, Melissa Z. ;
de Gonzalez, Amy Berrington ;
Schonfeld, Sara J. ;
Wentzensen, Nicolas ;
Brenner, Alina V. ;
Kitahara, Cari M. .
CANCER PREVENTION RESEARCH, 2014, 7 (04) :418-425
[5]   Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[6]   Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea [J].
Cho, Yoon Young ;
Kang, Min Jin ;
Kim, Soo Kyoung ;
Jung, Jung Hwa ;
Hahm, Jong Ryeal ;
Kim, Tae Hyuk ;
Nam, Joo Young ;
Lee, Byung-Wan ;
Lee, Yong-Ho ;
Chung, Jae Hoon ;
Song, Sun Ok ;
Kim, Sun Wook .
THYROID, 2018, 28 (07) :864-870
[7]   Pooled Analysis of Two Case-Control Studies in New Caledonia and French Polynesia of Body Mass Index and Differentiated Thyroid Cancer: The Importance of Body Surface Area [J].
Clero, Enora ;
Leux, Christophe ;
Brindel, Pauline ;
Truong, Therese ;
Anger, Antoinette ;
Teinturier, Cecile ;
Diallo, Ibrahima ;
Doyon, Francoise ;
Guenel, Pascal ;
de Vathaire, Florent .
THYROID, 2010, 20 (11) :1285-1293
[8]  
Corcoran C., 2022, StatPearls
[9]   AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: THE INCREASING INCIDENCE OF THYRIOD CANCER [J].
Davies, Louise ;
Morris, Luc G. T. ;
Haymart, Megan ;
Chen, Amy Y. ;
Goldenberg, David ;
Morris, John ;
Ogilvie, Jennifer B. ;
Terris, David J. ;
Netterville, James ;
Wong, Richard J. ;
Randolph, Gregory .
ENDOCRINE PRACTICE, 2015, 21 (06) :686-696
[10]   Relations of thyroid function to body weight [J].
Fox, Caroline S. ;
Pencina, Michael J. ;
D'Agostino, Ralph B. ;
Murabito, Joanne M. ;
Seely, Ellen W. ;
Pearce, Elizabeth N. ;
Vasan, Ramachandran S. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) :587-592